e-learning
resources
European Respiratory Review
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
Emily C. Bell, Narelle S. Cox, Nicole Goh, Ian Glaspole, Glen P. Westall, Alice Watson, Anne E. Holland
Source:
Eur Respir Rev, 26 (145) 170072; 10.1183/16000617.0072-2017
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Emily C. Bell, Narelle S. Cox, Nicole Goh, Ian Glaspole, Glen P. Westall, Alice Watson, Anne E. Holland. Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence. Eur Respir Rev, 26 (145) 170072; 10.1183/16000617.0072-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Short-term effects of supplemental oxygen during exercise in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Chronic obstructive pulmonary disease: current burden and future projections - Supplementary material
Source: Eur Respir J 2006; 27: 397-412
Year: 2006
Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016
Diffuse pulmonary ossification (DPO) in the absence of interstitial fibrosis: CT findings and clinical correlates
Source: Annual Congress 2011 - Vascular and parenchymal imaging
Year: 2011
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue?
Source: Virtual Congress 2020 – Exploring respiratory function
Year: 2020
Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006
No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559 m
Source: Eur Respir J 2010; 35: 812-820
Year: 2010
Cleaning agents and chronic lung disease: does the evidence support a link with COPD?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
A step test to assess exercise-related oxygen desaturation in interstitial lung disease
Source: Eur Respir J 2007; 29: 330-336
Year: 2007
Activated lymphoid follicles, sign of an immune response, are present in early idiopathic pulmonary fibrosis (IPF) and increase with disease progression.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012
Analyses of the relationship between ΔFVC, extent of fibrosis and extent of emphysema in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF clinical
Year: 2016
Effect of pulmonary rehabilitation on systemic inflammatory markers, muscle cross section area and functional parameters in interstitial lung disease
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
Etablishing rhesus model of pulmonary fibrosis (PF) for the new drug evaluation
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
The role of secondary pulmonary hypertension (SPH) in the limited exercise tolerance of patients with interstitial lung disease (ILD)
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept